Home Stock

Stock Research: Pfizer Limited

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Pfizer Limited

NSI:PFIZER INE182A01018
79
  • Value
    8
  • Growth
    54
  • Safety
    Safety
    89
  • Combined
    79
  • Sentiment
    1
  • 360° View
    360° View
    79
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Pfizer Limited is an India-based multinational pharmaceutical company. It focuses on Vaccines (Prevenar 13), Hospitals (advanced anti-infectives), Internal Medicine (respiratory, gastrointestinal, pain, cardiovascular), and Inflammation and Immunology (chronic autoimmune diseases, with brands like Enbrel). In the last fiscal year, the company had a market cap of $2848 million, profits of $166 million, and revenue of $267 million, with 1598 employees.

more

ANALYSIS: With an Obermatt 360° View of 79 (better than 79% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Pfizer Limited are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Pfizer Limited. The consolidated Growth Rank has a good rank of 54, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 54% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 89 which means that the company has a financing structure that is safer than 89% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 8 which means that the share price of Pfizer Limited is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 92% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 1, which means that professional investors are more pessimistic about the stock than for 99% of alternative investment opportunities. ...read more

more
Strongest Rank Sentiment
Weakest Rank Liquidity
Country USA
Industry Pharmaceuticals
Size Medium
Website pfizerltd.co.in
Index
Pfizer Limited stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 55 39 33
Growth
54 15 37 25
Safety
Safety
89 76 72 65
Sentiment
1 43 57 14
360° View
360° View
79 44 59 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
31 87 95 87
Opinions Change
50 23 50 50
Pro Holdings
n/a 51 58 6
Market Pulse
5 12 3 11
Sentiment
1 43 57 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 55 39 33
Growth
54 15 37 25
Safety Safety
89 76 72 65
Combined
79 48 47 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
38 19 14 16
Price vs. Earnings (P/E)
10 53 39 37
Price vs. Book (P/B)
30 55 45 31
Dividend Yield
1 60 63 60
Value
8 55 39 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
44 39 42 16
Profit Growth
77 39 27 65
Capital Growth
37 7 96 42
Stock Returns
50 35 29 31
Growth
54 15 37 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
78 74 66 78
Refinancing
44 64 66 46
Liquidity
97 61 63 61
Safety Safety
89 76 72 65

Similar Stocks

Discover high‑ranked alternatives to Pfizer Limited and broaden your portfolio horizons.

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

FedEx

NYQ:FDX
Country: USA
Industry: Air Freight & Logistics
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews